| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3278098 | Revista Española de Enfermedades Metabólicas Óseas | 2007 | 8 Pages |
Abstract
From among the treatments authorized for osteoporosis in Spain, only risedronate, alendronate, and strontium ranelate have demonstrated a protective effect in non-vertebral fractures.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
A. Castro Pérez de Castro,